Capital Fund Management (CFM)
UTHR icon

Capital Fund Management (CFM)’s United Therapeutics UTHR Stock Holding History

Capital Fund Management (CFM)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.7M Buy
53,037
+4,073
+8% +$2.29M 0.13% 190
2026
Q1 		$29M Buy
48,964
+15,605
+47% +$7.77M 0.13% 194
2025
Q4 		$16.3M Sell
33,359
-35,530
-52% -$16.5M 0.05% 581
2025
Q3 		$28.9M Buy
68,889
+20,410
+42% +$6.86M 0.08% 363
2025
Q2 		$13.9M Buy
48,479
+24,418
+101% +$7.3M 0.04% 593
2025
Q1 		$7.42M Sell
24,061
-16,172
-40% -$5.54M 0.02% 822
2024
Q4 		$14.2M Buy
40,233
+10,579
+36% +$3.89M 0.04% 602
2024
Q3 		$10.6M Buy
29,654
+6,134
+26% +$2.07M 0.03% 694
2024
Q2 		$7.49M Buy
23,520
+5,131
+28% +$1.36M 0.02% 801
2024
Q1 		$4.22M Buy
+18,389
New +$4.15M 0.01% 1126
2022
Q3 		– Sell
-12,857
Closed -$3.03M – 1670
2022
Q2 		$3.03M Sell
12,857
-3,643
-22% -$741K 0.03% 670
2022
Q1 		$2.96M Buy
+16,500
New +$3.14M 0.02% 782
2021
Q4 		– Sell
-12,611
Closed -$2.33M – 1871
2021
Q3 		$2.33M Sell
12,611
-2,988
-19% -$589K 0.02% 871
2021
Q2 		$2.8M Buy
15,599
+2,834
+22% +$540K 0.02% 801
2021
Q1 		$2.14M Buy
+12,765
New +$2.13M 0.02% 716
2020
Q1 		– Sell
-3,300
Closed -$291K – 2042
2019
Q4 		$291K Buy
+3,300
New +$290K ﹤0.01% 1612
2019
Q3 		– Sell
-87,669
Closed -$6.84M – 1913
2019
Q2 		$6.84M Buy
+87,669
New +$8.2M 0.06% 407
2018
Q4 		– Sell
-4,580
Closed -$531K – 2231
2018
Q3 		$586K Sell
4,580
-78,376
-94% -$9.69M ﹤0.01% 1545
2018
Q2 		$9.39M Sell
82,956
-21,648
-21% -$2.38M 0.05% 506
2018
Q1 		$11.8M Sell
104,604
-19,408
-16% -$2.47M 0.07% 389
2017
Q4 		$18.3M Buy
124,012
+62,524
+102% +$7.95M 0.1% 243
2017
Q3 		$7.21M Buy
61,488
+38,978
+173% +$4.98M 0.05% 422
2017
Q2 		$2.92M Buy
+22,510
New +$2.81M 0.02% 620
2017
Q1 		– Sell
-12,243
Closed -$1.76M – 1832
2016
Q4 		$1.76M Buy
+12,243
New +$1.56M 0.02% 810
2016
Q3 		– Sell
-1,910
Closed -$202K – 1811
2016
Q2 		$202K Sell
1,910
-97,194
-98% -$10.8M ﹤0.01% 1443
2016
Q1 		$11M Buy
+99,104
New +$12.5M 0.11% 229
2015
Q3 		– Sell
-14,379
Closed -$2.5M – 1682
2015
Q2 		$2.5M Sell
14,379
-31,046
-68% -$5.58M 0.03% 550
2015
Q1 		$7.83M Buy
45,425
+17,779
+64% +$2.71M 0.11% 236
2014
Q4 		$3.58M Buy
+27,646
New +$3.56M 0.04% 528
2014
Q3 		– Sell
-182,914
Closed -$16.2M – 1833
2014
Q2 		$16.2M Buy
182,914
+99,381
+119% +$9.56M 0.17% 141
2014
Q1 		$7.86M Buy
+83,533
New +$8.54M 0.1% 247
2013
Q3 		– Sell
-64,866
Closed -$4.74M – 1919
2013
Q2 		$4.27M Buy
+64,866
New +$4.18M 0.07% 401

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Capital Fund Management (CFM)'s UTHR Position: Q2 2026 in Review

Capital Fund Management (CFM) increased its United Therapeutics (UTHR) stake by 8.3% in Q2 2026, buying an estimated $2.29M and bringing the position to 53,037 shares worth $28.7M. The position accounts for 0.13% of the portfolio, ranked #190.

Capital Fund Management (CFM) first reported a position in UTHR in Q2 2013 and has held it in 32 quarters since. The position peaked at $29M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Capital Fund Management (CFM) held 53,037 shares of United Therapeutics worth $28.7M as of Q2 2026.
  • Capital Fund Management (CFM) bought 4,073 United Therapeutics shares in Q2 2026, an estimated $2.29M.
  • United Therapeutics made up 0.13% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #190 holding.
  • Capital Fund Management (CFM) first reported a position in United Therapeutics in Q2 2013 and has held it in 32 quarters since.
  • Capital Fund Management (CFM)'s United Therapeutics position peaked at $29M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.